Decreased Astrocytic CCL5 by MiR-324-5p Ameliorates Ischemic Stroke Injury via the CCR5/ERK/CREB Pathway
· 2026
DOI: 10.7554/elife.101719 ↗Kurz gefasst
Fachartikel, 2026. Verfasst von Jingxiu Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Technology, Shandong Second Medical University, Weifang, China. Hauptthemen laut MEDLINE: MicroRNAs, Chemokine CCL5, Astrocytes, Receptors, CCR5. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, MOST | National Natural Science Foundation of China, 山东省科学技术厅 | Natural Science Foundation of Shandong Province.
Themen: Schlaganfall
Abstract (Originalsprache)
Following ischemic stroke, Ccl5 mRNA expression increased, while miR-324-5p expression decreased in the peri-infarct cortex of middle cerebral artery occlusion (MCAO) mice. However, the roles of CCL5 and miR-324-5p in stroke remained largely unclear. Here, we show that inhibiting CCL5 using antibodies or miR-324-5p not only reduced infarct area and preserved neurological function in MCAO mice but also attenuated astrocyte reactivity and microglial activation, protected dendritic structures, and maintained spine density. In an astrocyte-neuron co-culture system after oxygen-glucose deprivation (OGD), inhibiting astrocytic CCL5 by antibody or miR-324-5p decreased neuronal apoptosis and preserved dendritic structure. Importantly, the suppression of CCL5 enhanced ERK/CREB pathway signaling both in vivo and in vitro. Consistent with these findings, the application of Maraviroc, a CCR5 antagonist, reduced infarct size, decreased neuronal apoptosis, and upregulated the ERK/CREB pathway in neurons treated with OGD. In conclusion, targeting the CCL5 pathway via miR-324-5p represents a promising therapeutic strategy for alleviating ischemic stroke damage through modulation of the neuronal CCR5/ERK/CREB pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Science and Technology, Shandong Second Medical University, Weifang, China.
- Affiliated Hospital of Shandong Second Medical University, Shandong Second Medical University, Weifang, China.
- Weifang People's Hospital, Shandong Second Medical University, Weifang, China.
ORCID-Profile: Chenxi Sun
Förderung
- National Natural Science Foundation of China
- MOST | National Natural Science Foundation of China
- 山东省科学技术厅 | Natural Science Foundation of Shandong Province
- Visiting Scholar Foundation of Shandong Province
Zitieren
APA
Li, J., Gao, K., Wang, L., Wang, X., Lian, K., Ma, Q., Ding, X., Wang, Y., Li, C., Gao, Z., & Sun, C. (2026). Decreased Astrocytic CCL5 by MiR-324-5p Ameliorates Ischemic Stroke Injury via the CCR5/ERK/CREB Pathway. . https://doi.org/10.7554/elife.101719
Vancouver
Li J, Gao K, Wang L, Wang X, Lian K, Ma Q, et al. Decreased Astrocytic CCL5 by MiR-324-5p Ameliorates Ischemic Stroke Injury via the CCR5/ERK/CREB Pathway. 2026. doi:10.7554/elife.101719
BibTeX
@article{Li2026,
author = {Li, Jingxiu and Gao, Keyuan and Wang, Lili and Wang, Xinrui and Lian, Kai and Ma, Qingchen and Ding, Xinmiao and Wang, Yubing and Li, Chao and Gao, Zhiqin and Sun, Chenxi},
title = {Decreased Astrocytic CCL5 by MiR-324-5p Ameliorates Ischemic Stroke Injury via the CCR5/ERK/CREB Pathway},
year = {2026},
doi = {10.7554/elife.101719}
}
EUVIMED